JP2016503293A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503293A5 JP2016503293A5 JP2015540154A JP2015540154A JP2016503293A5 JP 2016503293 A5 JP2016503293 A5 JP 2016503293A5 JP 2015540154 A JP2015540154 A JP 2015540154A JP 2015540154 A JP2015540154 A JP 2015540154A JP 2016503293 A5 JP2016503293 A5 JP 2016503293A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- composition
- cdr
- binding member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261722532P | 2012-11-05 | 2012-11-05 | |
| US61/722,532 | 2012-11-05 | ||
| EP12007503 | 2012-11-05 | ||
| EP12007503.1 | 2012-11-05 | ||
| PCT/EP2013/073009 WO2014068132A1 (en) | 2012-11-05 | 2013-11-05 | Binding members to il-1 beta |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018083160A Division JP6779252B2 (ja) | 2012-11-05 | 2018-04-24 | ＩＬ−１βへの結合メンバー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503293A JP2016503293A (ja) | 2016-02-04 |
| JP2016503293A5 true JP2016503293A5 (enExample) | 2016-12-08 |
| JP6333271B2 JP6333271B2 (ja) | 2018-06-06 |
Family
ID=47146146
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540154A Expired - Fee Related JP6333271B2 (ja) | 2012-11-05 | 2013-11-05 | ＩＬ−１βへの結合メンバー |
| JP2018083160A Expired - Fee Related JP6779252B2 (ja) | 2012-11-05 | 2018-04-24 | ＩＬ−１βへの結合メンバー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018083160A Expired - Fee Related JP6779252B2 (ja) | 2012-11-05 | 2018-04-24 | ＩＬ−１βへの結合メンバー |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US9404930B2 (enExample) |
| EP (2) | EP2914287B1 (enExample) |
| JP (2) | JP6333271B2 (enExample) |
| KR (1) | KR102345999B1 (enExample) |
| CN (1) | CN104870015B (enExample) |
| BR (1) | BR112015009892B1 (enExample) |
| CA (1) | CA2888583C (enExample) |
| MX (1) | MX374817B (enExample) |
| PL (1) | PL2914287T3 (enExample) |
| RU (1) | RU2711118C2 (enExample) |
| WO (2) | WO2014068132A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014068132A1 (en) * | 2012-11-05 | 2014-05-08 | Delenex Therapeutics Ag | Binding members to il-1 beta |
| EP3186390B1 (en) | 2014-08-29 | 2019-03-27 | Pioneer Hi-Bred International, Inc. | Methods and devices involving oil matrices |
| US9078427B1 (en) | 2014-08-29 | 2015-07-14 | Pioneer Hi Bred International Inc | Method of storing plant embryos |
| JP6202652B1 (ja) * | 2016-12-19 | 2017-09-27 | 株式会社ヘルスケアシステムズ | 抗エクオール抗体組成物及びその利用 |
| CN107362351B (zh) * | 2017-09-04 | 2020-11-10 | 上海市儿童医院 | Il-36r的拮抗剂在制备镇痛药物中的应用 |
| CN110818793A (zh) | 2018-08-14 | 2020-02-21 | 中山康方生物医药有限公司 | 抗IL-1β的抗体、其药物组合物及其用途 |
| WO2020176210A1 (en) | 2019-02-28 | 2020-09-03 | Exxonmobil Chemical Patents Inc. | Catalyst compositions and precursors, processes for making the same and syngas conversion processes |
| TWI793503B (zh) | 2020-01-20 | 2023-02-21 | 美商美國禮來大藥廠 | 抗IL-1β抗體 |
| TW202233237A (zh) | 2020-11-18 | 2022-09-01 | 瑞士商諾華公司 | 用於在治療ｎｌｒｃ４－ｇｏｆ炎性體病變中使用的雙特異性抗體 |
| US20240084039A1 (en) * | 2020-12-23 | 2024-03-14 | Numab Therapeutics AG | Antibody variable domains and antibodies having decreased immunogenicity |
| WO2022136693A1 (en) * | 2020-12-23 | 2022-06-30 | Numab Therapeutics AG | Antibody variable domains and antibodies having decreased immunogenicity |
| CN113908589B (zh) * | 2021-10-08 | 2022-09-27 | 天津工业大学 | 一种表面印迹抗体的疏水电荷诱导模式膜层析介质及其制备方法 |
| CN116410331B (zh) * | 2021-12-31 | 2024-01-30 | 合源生物科技(天津)有限公司 | 靶向cs1的嵌合抗原受体、靶向bcma/cs1的双特异性嵌合抗原受体及其应用 |
| CN114113634A (zh) * | 2022-01-24 | 2022-03-01 | 中国农业大学 | 一种检测非洲猪瘟病毒抗体的ELISA检测试剂盒以及protein L的应用 |
| WO2024258943A1 (en) * | 2023-06-13 | 2024-12-19 | Merck Sharp & Dohme Llc | Methods of using cyclic peptides for trapping interleukin-1 beta |
| CN117964755B (zh) * | 2023-12-26 | 2025-01-21 | 华润生物医药有限公司 | 抗tslp抗体及其用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0020685D0 (en) * | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
| US20030026806A1 (en) | 2000-10-27 | 2003-02-06 | Amgen Inc. | Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof |
| EP2332989B1 (en) | 2002-05-22 | 2015-04-01 | ESBATech, an Alcon Biomedical Research Unit LLC | Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| ES2567198T3 (es) * | 2003-01-24 | 2016-04-20 | Applied Molecular Evolution, Inc. | Antagonistas de la IL-1 beta humana |
| WO2006081139A2 (en) | 2005-01-26 | 2006-08-03 | Abgenix, Inc. | Antibodies against interleukin-1 beta |
| JP5089582B2 (ja) | 2005-06-07 | 2012-12-05 | エスバテック、アン アルコン バイオメディカル リサーチ ユニット、エルエルシー | ＴＮＦαを阻害する安定な可溶性抗体 |
| EP2163562B1 (en) * | 2005-06-21 | 2013-09-18 | XOMA Technology Ltd. | IL-1beta binding antibodies and fragments thereof |
| HRP20130042T1 (hr) * | 2008-06-06 | 2013-03-31 | Xoma Technology Ltd. | Postupci lijeäśenja reumatoidnog artritisa |
| GB0811574D0 (en) | 2008-06-24 | 2008-07-30 | Trillion Genomics Ltd | Characterising planar samples by mass spectrometry |
| GB2461273A (en) | 2008-06-24 | 2009-12-30 | Seppo Haekkinen | Load monitoring system |
| US9556265B2 (en) | 2008-06-25 | 2017-01-31 | Esbatech, An Alcon Biomedical Research Unit Llc | Solubility optimization of immunobinders |
| CN104004094B (zh) | 2008-06-25 | 2017-09-22 | 艾斯巴技术-诺华有限责任公司 | 使用通用抗体构架进行的兔抗体的人源化 |
| JP2012502059A (ja) | 2008-09-05 | 2012-01-26 | ゾーマ テクノロジー リミテッド | ＩＬ−１β関連疾患を処置または予防するための方法 |
| RU2013115927A (ru) * | 2010-09-10 | 2014-10-20 | Апексиджен, Инк. | АНТИТЕЛА ПРОТИВ ИЛ-1β И СПОСОБЫ ПРИМЕНЕНИЯ |
| WO2014068132A1 (en) * | 2012-11-05 | 2014-05-08 | Delenex Therapeutics Ag | Binding members to il-1 beta |
-
2013
- 2013-11-05 WO PCT/EP2013/073009 patent/WO2014068132A1/en not_active Ceased
- 2013-11-05 US US14/072,165 patent/US9404930B2/en active Active
- 2013-11-05 BR BR112015009892-4A patent/BR112015009892B1/pt not_active IP Right Cessation
- 2013-11-05 RU RU2015120450A patent/RU2711118C2/ru active
- 2013-11-05 CN CN201380064089.1A patent/CN104870015B/zh not_active Expired - Fee Related
- 2013-11-05 KR KR1020157013550A patent/KR102345999B1/ko not_active Expired - Fee Related
- 2013-11-05 CA CA2888583A patent/CA2888583C/en active Active
- 2013-11-05 JP JP2015540154A patent/JP6333271B2/ja not_active Expired - Fee Related
- 2013-11-05 EP EP13786473.2A patent/EP2914287B1/en active Active
- 2013-11-05 PL PL13786473T patent/PL2914287T3/pl unknown
- 2013-11-05 EP EP20163414.4A patent/EP3750917A1/en not_active Withdrawn
- 2013-11-05 MX MX2015005384A patent/MX374817B/es active IP Right Grant
-
2014
- 2014-11-05 WO PCT/EP2014/073772 patent/WO2015067636A1/en not_active Ceased
-
2016
- 2016-07-06 US US15/202,982 patent/US10077302B2/en active Active
-
2018
- 2018-04-24 JP JP2018083160A patent/JP6779252B2/ja not_active Expired - Fee Related
- 2018-08-30 US US16/118,124 patent/US10626171B2/en active Active
-
2020
- 2020-03-18 US US16/822,952 patent/US11267884B2/en active Active
-
2022
- 2022-01-28 US US17/587,751 patent/US20220220195A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503293A5 (enExample) | ||
| AU2025283534A1 (en) | TREM2 antigen binding proteins and uses thereof | |
| CN105849124B (zh) | 双重特异性抗体 | |
| JP2022160404A (ja) | ヒトｉｌ－４受容体に対する高親和性ヒト抗体 | |
| TWI769537B (zh) | 標靶ｂｃｍａ的抗體、雙專一性抗體及其用途 | |
| AU2012315474B2 (en) | Antibodies against TL1a and uses thereof | |
| JP6779252B2 (ja) | ＩＬ−１βへの結合メンバー | |
| RU2016141561A (ru) | Связывающие элементы к фно-альфа | |
| CN115397852B (zh) | 工程化抗il-2抗体 | |
| US12325739B2 (en) | Bispecific SARS-CoV-2 antibodies and methods of use | |
| JP2012518425A5 (enExample) | ||
| RU2012130840A (ru) | Соединения | |
| JP2016503412A5 (ja) | Ｉｌ−６アンタゴニストおよびその使用 | |
| CN104903352A (zh) | 多价结合蛋白组合物 | |
| WO2014095808A1 (en) | Antibodies against il-1 beta | |
| CN109069606B (zh) | 干扰素β抗体及其用途 | |
| CN106565840B (zh) | 抗乙肝表面抗原的抗体及其用途 | |
| TWI815136B (zh) | 一種雙特異性抗體及其用途 | |
| TWI801425B (zh) | Il-5 抗體、其抗原結合片段及醫藥用途 | |
| WO2022100664A1 (zh) | 一种tslp抗原结合蛋白及其应用 | |
| WO2026012501A1 (zh) | 一种抗ngf单克隆抗体及其应用 | |
| CN114846026A (zh) | 对人il-13和il-17具有结合特异性的多特异性抗体 | |
| WO2025153079A1 (en) | Method of treatment | |
| JPWO2020041537A5 (enExample) | ||
| TW202413405A (zh) | 抗體、其抗原結合片段及其藥物用途 |